Dr. Erick W. Hjortsvang, MD

Dr. Hjortsvang practices at Pcr Oncology in Arroyo Grande, California.

Dr. Hjortsvang's NPI, 1275611857, was assigned on November 1, 2006. Dr. Hjortsvang graduated from St. George's University School of Medicine in 1999. Dr. Hjortsvang holds California license A79589.

Dr. Hjortsvang's primary practice is Pcr Oncology, at 584 Camino Mercado, Arroyo Grande, CA 93420-1816. The practice phone is (805) 474-9143.

Dr. Hjortsvang's primary practice is Pcr Oncology in Arroyo Grande, California. Dr. Hjortsvang is also affiliated with Dignity Health - Marian Regional Medical Center. The medical group on file is PCR Oncology. Dmand AI also links Dr. Hjortsvang to 2 more hospitals and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hjortsvang practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Hjortsvang's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Hjortsvang is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Hjortsvang's licenses on file in 2 states: California and Oklahoma.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease, lung cancer and lymphoma among the conditions Dr. Hjortsvang treats.

CMS data shows 2,327 Medicare services from Dr. Hjortsvang across 13 procedure codes in 2024, for 224 Medicare patients. Medicare paid $124,430 for them. Every service was in an office.

CMS counts 224 Medicare patients who saw Dr. Hjortsvang in 2024. The largest group is 75 to 84, with 107 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hjortsvang's median patient age at 73, with 58% women.

In 2024, Dr. Hjortsvang wrote 1,135 Medicare Part D claims for 143 patients. 88% of them were for generic drugs. CMS names the drug for 856 of them, across 28 drugs with 11 or more claims each, at $881,945 in total drug cost. In 2023, CMS named 792 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Hjortsvang for performance year 2024, reported individually. Dr. Hjortsvang accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Hjortsvang. Dr. Hjortsvang's most frequent co-author is Rammurti Kamble, MD.

CMS Open Payments shows 197 general payments to Dr. Hjortsvang from 34 drug and device companies from 2016 to 2025. Gifts make up the largest share, 42% of the total. Novartis Pharmaceuticals Corporation paid the most, $5,008.

Dmand AI lists 1 award for Dr. Hjortsvang, most recently CMS Stage 1 2012 in 2011.

Dr. Hjortsvang graduated from St. George's University School of Medicine in 1999. Dr. Hjortsvang is a member of ASCO.

Dr. Hjortsvang is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.